RecallDepth
Class II Ongoing

chlorproMAZINE Hydrochloride Tablets, USP 100 mg, Rx Only, 100 Tablets per bottle, Manufactured for: Glenmark Pharmaceuticals Inc., USA, Mahwah, NJ 07430, Product of India, NDC 68462-864-01

This recall is currently active, issued April 9, 2025. It was issued by Glenmark Pharmaceuticals Inc., Usa.

Company
Glenmark Pharmaceuticals Inc., Usa
Recall Initiated
March 11, 2025
Posted
April 9, 2025
Recall Number
D-0309-2025
Voluntary / Mandated
Voluntary: Firm initiated
Quantity
8160 bottles
Firm Location
Mahwah, NJ, United States
Official Source
View on FDA website ↗

Reason for Recall

CGMP deviations: presence of N-Nitroso-Desmethyl Chlorpromazine impurity above the recommended interim limit.

Distribution

Nationwide in the USA and PR

Lot / Code Info

Lot#s: 17232222 and 17232237, Exp 10/31/2025

More recalls by Glenmark Pharmaceuticals Inc., Usa

View all recalls by this company →

Other recent Class II Drug recalls